Clinical Trial Update: A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) [Phase 3]

View source ↗

Summary

A randomized Phase 3 trial comparing avelumab with axitinib against sunitinib in advanced renal cell carcinoma has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Avelumab (avelumab)
• Axitinib (Axitinib)
• Sunitinib (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Renal Cell Cancer | Phase 3 | Status: COMPLETED | Results posted: 2024-10-29